Clinical studies recruiting near Tarzana

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Valiance Clinical Research-Tarzana-68237 · Boehringer Ingelheim · NCT07220083 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Cedars-Sinai Cancer - Tarzana · Alliance for Clinical Trials in Oncology · NCT06876714 A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
Phase N/A · Valiance Clinical Research (JPJ Research) - Site Number: 840 · Sanofi · NCT07556159 A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · FON-10409, Tarzana, CA · Colorado Prevention Center · NCT06033950 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Cedars-Sinai Cancer - Tarzana · Canadian Cancer Trials Group · NCT06592924 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · Valiance Clinical Research - Tarzana: 8400023 · Sanofi · NCT07184931 Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Inva
Phase 2 · Cedars-Sinai Cancer - Tarzana · National Cancer Institute (NCI) · NCT07061964 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Cedars-Sinai Cancer - Tarzana · NRG Oncology · NCT04852887 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Cedars-Sinai Cancer - Tarzana · National Cancer Institute (NCI) · NCT06058377 Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pM
Phase 2/Phase 3 · Valiance Clinical Research - Internal Medicine · Vertex Pharmaceuticals Incorporated · NCT07204275 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Cedars-Sinai Cancer - Tarzana · SWOG Cancer Research Network · NCT06616584 A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Phase 2 · Valiance Clinical Research - Tarzana · Apollo Therapeutics Ltd · NCT07599813 A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Dis
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT06749457 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Cedars-Sinai Cancer - Tarzana · SWOG Cancer Research Network · NCT03851445 Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Phase 2/Phase 3 · Valiance Clinical Research - Tarzana · Olatec Therapeutics, Inc. · NCT05658575 Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease
Phase 1/Phase 2 · Valiance Clinical Research · NKGen Biotech, Inc. · NCT06189963 Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer
Phase 2 · CS Cancer at Valley Oncology Medical Group · Zachary Zumsteg · NCT06445114 Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After
Phase 3 · Cedars-Sinai Cancer - Tarzana · Alliance for Clinical Trials in Oncology · NCT05812807 IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
Phase 2 · CS Cancer at Valley Oncology Medical Group · Alice Chung · NCT06092892 A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopul
Phase 3 · Research Site · AstraZeneca · NCT06283966 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Ventana Surgical Center · Stryker Instruments · NCT03072927 A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a
Phase 3 · Research Site · AstraZeneca · NCT07000357 A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Phase 3 · Valiance Clinical Research · Novo Nordisk A/S · NCT07567001 Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung
Phase 2 · Cedars-Sinai Cancer - Tarzana · SWOG Cancer Research Network · NCT06031688 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · Valiance Clinical Research - Tarzana - Site Number: 8400023 · Sanofi · NCT07184996 Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
NA · Providence Cedars-Sinai Tarzana Medical Center · Swedish Medical Center · NCT07108660 A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NA · Valiance Clinical Research - Tarzana · Cleerly, Inc. · NCT06112418 A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure P
Phase 3 · Tarzana, CA Investigative Site 10409 · Colorado Prevention Center · NCT06008197

Look up another city

Look up another condition